The Intercept @theintercept
In May, the Department of Health and Human Services said it anticipated that the @US_FDA would approve both MDMA and psilocybin for treatment of PTSD and depression, respectively, within the next two years. https://t.co/klt4mPOIry — PolitiTweet.org